DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2228893/macy-s-m-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2228893 Feb 20, 2024 - In the most recent trading session, Macy's (M) closed at $19.26, indicating a -1.03% shift from the previous trading day. 0

https://seekingalpha.com/news/4068613-healthcare-dealmakers-see-increased-ma-valuations-in-2024-kpmg?source=feed_sector_healthcare Feb 19, 2024 - Corporate and private equity dealmakers are anticipating an uptick in healthcare and life sciences M&A activity this year, with higher valuations, according to KPMG survey. 0

https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-lly-s-q4-earnings-nvo-nvs-mrk-s-m-a-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2224190 Feb 09, 2024 - Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements. 0

https://www.zacks.com/stock/news/2220331/bears-are-losing-control-over-b-m-european-value-retail-sa-unsponsored-adr-bmrry-here-s-why-it-s-a-buy-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2220331 Feb 02, 2024 - B&M European Value Retail SA Unsponsored ADR (BMRRY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. 0

https://www.zacks.com/stock/news/2220253/m-a-com-mtsi-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220253 Feb 02, 2024 - Although the revenue and EPS for M/A-Com (MTSI) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. 0

https://www.zacks.com/stock/news/2217285/factors-setting-the-tone-for-m-i-homes-mho-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217285 Jan 29, 2024 - M/I Homes' (MHO) fourth-quarter performance is likely to reflect tough year-over-year comparisons, thanks to rising rates. Yet, the lack of existing homes on the market will drive demand. 0

https://www.zacks.com/stock/news/2215875/m-a-com-mtsi-expected-to-beat-earnings-estimates-can-the-stock-move-higher?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2215875 Jan 25, 2024 - M/A-Com (MTSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2215374/macy-s-m-stock-falls-amid-market-uptick-what-investors-need-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2215374 Jan 24, 2024 - In the closing of the recent trading day, Macy's (M) stood at $18.14, denoting a -0.27% change from the preceding trading day. 0

https://seekingalpha.com/article/4664292-m-tron-industries-growing-stature-wait-for-pullback?source=feed_all_articles Jan 22, 2024 - M-tron Industries (MPTI) is a high-performing RF components provider experiencing impressive growth, but caution is advised on its current stock level. Read more. 0

https://seekingalpha.com/article/4663655-mi-homes-cheap-homebuilder-primed-for-growth?source=feed_all_articles Jan 18, 2024 - M/I Homes is primed for strong growth in the coming years, as the demand for homes continues to outstrip supply. Find out why MHO stock is a Buy. 0